Now, at a press conference in Penzberg, he and the German Health Minister Jens Spahn were able to announce that an antibody test developed in the small Bavarian town by a German subsidiary of the Swiss pharmaceutical company Roche had just been approved by the United States Food and Drug Administration.
The company claimed that their new antibody test was 99.8 percent accurate. That gave Roche one more reason to invest another EUR 400 million into the Penzberg plant, allowing the German subsidiary to manufacture five million tests every month. The state of Bavaria also invested EUR 40 million.
“This is not just a regional event – it’s an important international step in the fight against the coronavirus,” said Söder.